We are living in a dynamic time of drug development and innovation with many beneficiaries—the most important being the patient. These developments include everything from exciting gene therapies for ...
Dev Technology Group, a member of the Government Technology & Services Coalition (GTSC) and a fast-growing leader in federal IT services, has been awarded an $82 million task order to support the ...
The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback